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Abstract 
This paper focuses on how a firm’s characteristics affect the market valuation of 
its research and development (R&D) spending. We derive a valuation model 
based on the capital market arbitrage condition. The estimation of this model by 
using the Generalized Method of Moments and data from the eurozone 
countries yields interesting results. Several firm characteristics (namely, size, 
firm growth and market share) are found to positively affect the relationship 
between firm value and R&D spending, while others (specifically, free cash 
flow, dependence on external finance, labour intensity and capital intensity) 
exert a negative effect. Therefore, the effectiveness of the R&D spending 
depends on the firm characteristics. 
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Over the last 10 years, the academic literature has provided evidence on the 
importance of the role played by research and development (hereafter R&D) in 
the economic growth (see, for instance; Jones, 1995; and, more recently, Bowns 
et al., 2003; Arnold, 2006). As a result, scholars have paid increasing attention 
to the R&D spending, which is not considered as a cost anymore, but rather as a 
value-increasing investment in that R&D spending yields some supra-normal 
profits.  
Moreover, the seminal work by Griliches (1981) draws attention to the 
extent that R&D spending creates intangible capital for a firm, and indicates 
that the market should show it up in the valuation of the firm. More recently, 
several empirical studies analyze the market response to R&D spending, and 
their results indicate that, in general, R&D investments are positively valued by 
the market (see, for instance, Doukas and Switzer, 1992; Chauvin and Hirschey, 
1993; Szewczyk et al., 1996; Chen and Ho, 1997; Chan et al., 2001; Bae and 
Kim, 2003; Eberhart et al., 2004; Cannolly and Hirschey, 2005). Furthermore, 
some of these papers indicate that the market response to the R&D spending 
depends on firm size.  For instance, Cannolly and Hirschey (2005) find support 
for the size advantages to the valuation effects of R&D investments.  
The stock market valuation of R&D spending is also affected by the 
financial environment, as shown by Booth et al. (2006). Their results support 
the notion that the relative size of the equity and private loan markets influence 
the way in which R&D is valued. Specifically, they document that the greater 
the portion of equity financing (or the lower the portion of bank loan financing), 
the stronger the market valuation of R&D spending. Therefore, Booth et al. 
(2006) conclude that the institutional source of financing matters.  
In this context, the aim of this paper is to analyse how several firm 
characteristics moderate the relationship between firm value and R&D 
spending. Our idea is that the market valuation of R&D spending is not only 
affected by the financial environment (see Booth et al., 2006), but also by some 
firm characteristics besides size (see Cannolly and Hirschey, 2005). Although 
there is no previous evidence on this point, there are some studies that has 
identified several firm characteristics (such as size, firm growth, free cash flow, 
market share, external finance dependence, labour intensity and capital 
intensity) as determinants of a firm’s R&D (see, for instance, Blundell et al., 
1999; Galende and Suárez, 1999; Del Monte and Papagni, 2003; Negassi, 
2004). Therefore, in this paper we go a step forward in that we investigate 
whether or not certain firm characteristics, besides being themselves 
determinants of R&D spending, also play an important role in moderating the 
relationship between firm value and R&D spending. Accordingly, we pose 




several hypotheses that allow us to analyse how size, growth, free cash flow, 
market share, external finance dependence, labour intensity and capital intensity 
influence the positive relationship between R&D and firm value. 
To achieve our goal, we first derive a valuation model based on the 
capital market arbitrage condition. This model shows that the firm value 
depends on the residual income and the R&D spending and, therefore, it is a 
perfect tool to study how firm characteristics affect the market valuation of 
R&D spending. In this way, our study relies on strong theoretical arguments for 
each firm characteristic and on the results from the estimation of the valuation 
model. The estimation is carried out by the Generalized Method of Moments, 
hence we use the panel data methodology that eliminates the individual 
heterogeneity and controls for endogeneity problems. Since the data quality 
requirements of this methodology are very high, we have extracted our data 
from an international database (Worldscope) and for all the eurozone countries†. 
Our results reveal that the positive relationship between firm value and 
R&D spending is moderated by several firm characteristics. Specifically, size 
exerts a positive effect on this relation due to economies of scale, easier access 
to capital markets and R&D cost spreading. A positive effect is also found 
regarding firm growth in that a high rate of growth allows the firm to take 
greater advantage of the supra-normal profits arising from R&D projects. In 
contrast, free cash flow negatively affects the market valuation of R&D 
spending, since firms with high levels of free cash flow could use these funds to 
undertake negative net present value (NPV) R&D projects. Interestingly, we 
find that market share affects the relationship between firm value and R&D 
spending rather than firm value and, as a result, the supra-normal profits are 
highly dependent on the amount of R&D spending. The dependence of external 
financing negatively affects the market valuation of R&D spending because of 
the higher information asymmetry associated with R&D projects. Labour and 
capital intensity both negatively influence the impact of R&D spending on firm 
value; the first one because the supra-normal profits are diluted between 
employees, and the second one because capital intensive firms face greater 
financial constrains. 
The remainder of the paper is organised as follows. In Section 2, we 
derive the valuation model depending on residual income and R&D spending, 
and explain the theoretical arguments behind our hypotheses.  Section 3 
describes our data set and the econometric method used to test our hypotheses. 
The results are discussed in Section 4, and the last section presents the 
conclusions. 
                                                 
† Note that the eurozone countries provide us with an ideal environment for our market share 
arguments. 




2. Model and Hypotheses 
 
The development of our model to study the relationship between R&D and firm 
value is based on the well-known capital market arbitrage condition (see, for 
instance, Whited, 1992, and Blundell et al., 1992). According to this condition, 
the net after-tax return for shareholders in the firm i during period t is obtained 
in two ways: current dividends and capital appreciation. Therefore, shareholders 
will maintain their shares as long as the return obtained equals their required 
after-tax return. This equilibrium can be expressed by the following equation: 
1,1, )( ++ +−= titittititit DEVVEVr                                                                         (1) 
where Vit is the value of firm i at the end of period t, Di,t+1 are the dividends paid 
by firm i at time t+1, rit is the after-tax return required by shareholders, and Et is 
the conditional expectation on information known at moment t. 
















EV                                                                                      (2) 
The value of dividends may be calculated by using the following Clean 
Surplus Relation (CSR): 
itittiit DBVBV −+= − π1,                                                                                  (3) 
The CSR in Equation (3) proposes that the book value of equity in period 
t (BVit) depends on the book value of equity at the beginning of the period (BVi,t-
1), the net income (πit) and the dividends (Dit). Solving Equation (3) for 
dividends, we obtain: 
itittiit BVBVD −+= − π1,                                                                                  (4) 



















                                    (5) 


























                                         (6) 
                                                 
‡ Details will be provided by authors upon request. 




Following Dechow et al. (1999) and Myers (1999), we assume that the 
last term in Equation (6) is zero. In addition, as usual in the economic literature, 
we consider that the residual income is: 
1,,, −+++ −= jtijtijti rBVRI π                                                                                 (7) 














EBVV                                                                               (8) 
Consequently, the attention should be paid to the second term in Equation 
(8). We assume that the expected residual income conditional on date t 
information depends on two factors. First, the residual income could have either 
a trend (increasing or declining) or be constant. For instance, Green et al. (1996) 
assume that the expected values of future residual incomes can be modelled as 
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The other two possible outcomes refer to an increasing trend for the 
expected values of future residual incomes at rate δ, and a constant value for the 









































+                                                                       (11) 
Second, Sougiannis (1994) argues that the impact of R&D on market 
value can be obtained indirectly through earnings. The idea is that the impact of 
past R&D expenditures on current market value can be captured by the 
investments undertaken by the firm, which yield earnings and, as a 
consequence, have a substantial impact on the current residual income. 
Furthermore, Sougiannis (1994) shows that this effect is much larger than the 
direct effect of new R&D information conveyed directly by R&D measures. 
Therefore, past R&D expenditures should be a factor to explain the residual 
income conditional on date t information. The point is how many lags should be 
considered. According to Sougiannis (1994), lagged values of R&D rarely 
convey addition information in explaining market value, once current residual 
income has been included as an explanatory variable on the valuation model. As 
a result, the best solution is to enter the current R&D spending into the 
valuation model, and use several lagged R&D values to estimate its current 
value by an instrumental variables method. In this paper, as explained in Section 




3.2, we use the Generalized Method of Moments, since this method embeds the 
other instrumental variables methods as special cases (see Ogaki, 1993).  
Taking into account the two factors abovementioned, the conditional 















ββ                                                           (12) 
where RDit stands for the research and development spending, and eit  is a 
random error arising from the approximation process of the expectation term. β1 
and β2 are the parameters of the model, the value of the former being dependent 
on the assumptions made in Equations (9), (10) or (11). 
Substituting the expectation in Equation (12) into Equation (8) yields the 
following regression model: 
+= itit BVV ititit eRDRI ++ 21 ββ                                                                    (13) 
As a method of controlling for size, all the variables in Equation (13) 
have been scaled by the replacement value of total assets§, and rearranging 
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Actually, the left hand side term in our model is the difference between 
market and book value of equity. From a theoretical point of view, this 
difference captures the fluctuation of firm value when the explanatory variables 
change. In fact, our dependent variable is adjusted by the changes in market 
value that are due to the purchase of new assets.  Therefore, by construction, our 
valuation model tells us that the residual income and R&D variables are 
positively related to firm value.   
In this paper, we focus on the market valuation of R&D spending. 
Therefore, the first outcome from our valuation model is that there is a positive 
relationship between firm value and R&D spending. This theoretical result is 
consistent with prior empirical studies (see, for instance, Chan et al., 2001; 
Booth et al., 2006), and it thus provides theoretical basis for our first hypothesis: 
Hypothesis 1. The research and development spending positively affects 
firm value. 
Since Schumpeter (1961), scholars have widely studied the relationship 
between R&D and firm size. As surveyed in Lee and Sung (2005), diverse 
results have been found by the empirical literature.  Some studies find a linear 
                                                 
§ Deflating by controlling for size is a usual way to avoid heteroscedasticity problems in 
econometric models. 




and positive relationship, while others suggest that R&D and firm size are 
independent. The earliest studies of the relationship between firm size and R&D 
find a positive relation**, which is interpreted as support for the Schumpeterian 
hypothesis. Furthermore, Arvanitis (1997) finds that the positive relationship 
between R&D expenditures and firm size depends on the firm industry. 
However, Cohen et al. (1987) investigate the Schumpeterian hypothesis and 
find that, overall, firm size has a statistically insignificant effect on R&D 
intensity when either fixed industry effects or measured industry characteristics 
are taken into account. Recently, Lee and Sung (2005) find that the R&D-size 
relation is probably stronger for industries with high technological opportunity. 
Note that this result is consistent with previous findings already reported by 
Cohen and Klepper (1996).   
More important than the relationship between R&D and size is how size 
moderates the relationship between R&D and value. Cannolly and Hirschey 
(2005) show findings supporting the importance of size advantages to the 
valuation effects of R&D spending. This result is consistent with Chauvin and 
Hirschey (1993), who find that R&D activity of larger firms appears to be 
relatively more effective than that of smaller ones, based on a market value 
perspective. Moreover, the advantages in technological competition 
(particularly the economies of scale in R&D, the easier access to capital markets 
and, sometimes, the R&D cost spreading) are commonly attributed to large 
firms (see Cohen and Klepper, 1996).  Within this context, we use our valuation 
model to go further in the analysis of the role played by firm size in moderating 
the relationship between R&D and value. Accordingly, we pose our second 
hypothesis: 
Hypothesis 2. The impact of research and development on firm value is 
greater for larger than for smaller firms. 
To test this hypothesis, we extend on the model in Equation (14) by 
interacting R&D with a dummy variable that distinguishes between large and 
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where DSit is a dummy variable equal to 1 if the firm is larger than the sample 
mean, and 0 otherwise. Firm size is measured as the natural logarithm of the 
replacement value of total assets. According to this model, the coefficient of 
R&D for small firms is β2 (since DSit takes value zero); whereas β2+α1 is the 
coefficient for large firms (since DSit takes value one). In this last case, if both 
parameters are significant, a linear restriction test is needed in order to know 
                                                 
** See Cohen and Klepper (1996) for details about these papers. 




whether their sum (β2+α1) is significantly different from zero. Hence the null 
hypothesis of no significance is H0:β2+α1=0. 
Economic literature assumes that R&D spending facilitates the success of 
the firm in the product market and, as a result, the R&D spending leads to a 
higher rate of growth. However, Del Monte and Papagni (2003) summarize the 
results found by different studies over the last 20 years.  Based on the analysis 
of these studies, they come to the conclusion that a significant relationship 
between research intensity and firm growth has not always been found. 
Nevertheless, Del Monte and Papagni (2003) provide evidence revealing a 
positive relationship between R&D and the rate of growth. Furthermore, they 
argue that the variable proxying for innovation efforts (including R&D) could 
be endogenous. This means that firms with higher rate of growth would increase 
their size and, according to the Schumpeterian hypothesis, they will undertake 
more R&D projects. In this context, our study focuses on how a firm’s growth 
affects the market valuation of its R&D spending. Our argument is that firms 
growing at a higher rate will make the most of the supra-normal profits arising 
from the R&D projects and, consequently, the market will provide them with a 
better valuation than that of the remaining firms.  Therefore, our third 
hypothesis would be as follows: 
 Hypothesis 3. The impact of research and development on firm value is 
greater for firms with   higher rate of growth than for firms with lower rate of 
growth. 
This hypothesis can be tested by substituting the dummy variable in 
Equation (15) by another dummy variable, DGit, which takes value 1 for firms 
whose rate of growth is above the sample mean, and 0 otherwise. 
Another firm characteristic that may influence the relationship between 
R&D and firm value is the free cash flow. Jensen (1986) defines a firm’s free 
cash flow as the cash flow in excess of that required to fund all positive NPV 
projects when discounted at the relevant cost of capital. According to Jensen’s 
theory, firms with a high level of free cash flow (hereafter, HFCF firms) are 
prone to use these funds in negative NPV projects. Several studies on 
investment find support for Jensen’s theory (see, for example, Del Brio et al., 
2003a and 2003b) in that firms having low (high) free cash flow level are 
expected to experience positive (negative) market reaction to investment 
announcements. However, there are other studies (see, for instance, Szewczyk 
et al., 1996, and Chen and Ho, 1997) that do not find enough evidence to 
support this theory, although this lack of support may be due to the fact that 
their measure of free cash flow is a cash flow measure. In addition, except for 
Szewczyk et al. (1996), the abovementioned studies are focused on tangible 
assets investments. Consequently, our study contributes to this strand of 
literature by analyzing how the level of free cash flow affects the relationship 




between R&D spending and firm value.  According to Jensen’s theory, the 
effect of HFCF firms’ R&D projects on their market value should be lower than 
that of low free cash flow firms (LFCF firms), in that the managers of LFCF 
firms are not so encouraged to undertake negative NPV projects. Consequently, 
our fourth hypothesis would be as follows: 
Hypothesis 4. The impact of research and development on firm value is 
greater for firms with low free cash flow levels than for ones with high free cash 
flow levels. 
We test this hypothesis by substituting the dummy variable in Equation 
(15) by another dummy variable, DFCFit, which takes value 1 for firms with a 
level of free cash flow higher than the sample mean, and 0 otherwise. In order 
to avoid that an unsuitable measure of free cash flow enters any bias in our 
study, we follow Miguel and Pindado (2001) in the construction of the free cash 
flow variable. The idea is to build an index that takes high values when cash 
flow is high and investment opportunities low, and low values vice versa. 
Consequently, our measure of free cash flow is the result of the interaction 
between cash flow and the inverse of investment opportunities (see Appendix). 
Recent literature has pointed out the influence of the relationship between 
market share and R&D spending on firm value. In fact, there is previous 
evidence suggesting that market share and R&D are complementary to each 
other in firms market valuation (see Nagaoka, 2004).  Blundell et al. (1999) 
investigate the relationship between innovation and market share, and find that 
firms with high market share innovate more and, hence, their market valuation 
is higher. In order to check the robustness of this result, they enter into their 
model the interaction between innovation stock and market share, finding a 
positive coefficient for the interaction term. Given that the R&D process is a 
wellspring of innovation (see Booth et al., 2006), these findings show evidence 
on the importance of market share in moderating the relationship between R&D 
and firm value.  In addition, Blundell et al. (1999) suggest that such positive 
influence plays a considerable role in creating barriers to entry that, hence, 
should be captured by firm value. To provide additional evidence on this matter, 
we test the advantages of market share, and hence we pose our fifth hypothesis: 
 Hypothesis 5. The impact of research and development on firm value is 
greater for firms with high market share than for ones with low market share. 
This hypothesis can be tested by substituting the dummy variable in 
Equation (15) by another dummy variable, DMSit, which takes value 1 for firms 
whose market share level is larger than the sample mean, and 0 otherwise. 
Market share is calculated as described in the Appendix.  
The external finance dependence (hereafter EFD) is another firm 
characteristic that is expected to moderate the relationship between R&D and 




firm value.  We follow Rajan and Zingales (1998), and we define EFD as 
capital expenditures minus cash flow divided by capital expenditures. 
Therefore, the EFD measure captures the part of a firm’s investments that 
cannot be financed by internal resources and, in consequence, that requires the 
firm to obtain external funds. Rajan and Zingales (1998) show that industries 
with EFD grow relatively faster in countries with developed financial markets. 
These authors also argue that the bank-based system has a comparative 
advantage when financing the industries intensive in tangible assets. 
Consequently, it would be more difficult to raise funds to undertake investments 
in intangibles assets. Moreover, a traditional interpretation of the innovation-
market power correlation is that failures in financial markets force firms to rely 
on their own retained earnings to finance their innovation (see Blundell et al, 
1999). Therefore, in particular for R&D, the availability of internal financial 
resources would be less costly, considering that the extent of information 
asymmetry associated with R&D is larger than that associated with tangible 
assets, due to the relative uniqueness of R&D (see Aboody and Lev, 2000).  
Accordingly, we derive the following hypothesis.   
 Hypothesis 6. The higher the external finance dependence, the lower the 
impact of research and development on firm value. 
This hypothesis can be tested by substituting the dummy variable in 
Equation (15) by another dummy variable, DEFDit, which takes value 1 for 
firms whose external finance dependence level is lager than the sample mean, 
and 0 otherwise. 
The relationship between human capital and R&D activities has drawn 
attention from the empirical research. Galende and Suárez (1999) find evidence 
supporting the hypothesis that a high stock of qualified human capital increases 
the probability of R&D activities. In the same vein, Gustavsson and Poldahl 
(2003) show the importance of human capital for R&D spending. Furthermore, 
Beck and Levine (2002) focus on assessing whether R&D-intensive and labour-
intensive industries grow faster depending on the orientation of the financial 
system (bank-based versus market-based). However, they do not find evidence 
supporting that the orientation of the financial system favours labour-intensive 
industries. We go a step forward in studying labour-intensive firms instead of 
industries. Our argument is that the effect of labour intensity on the relationship 
between firm value and R&D spending is negative, in that the supra-normal 
profits of R&D spending are diluted between employees, especially when 
employees have been hardly involved in the firm’s R&D projects. As a result, 
our seventh hypothesis would be as follows:  
Hypothesis 7. The higher the labour intensity, the lower the impact of 
research and development on firm value. 




We test this hypothesis by substituting the dummy variable in Equation 
(15) by another dummy variable, DLIit, which takes value 1 for firms whose 
labour intensity level is higher than the sample mean, and 0 otherwise. We 
defined the labour intensity as the ratio between the number of employees and 
sales revenue. 
 Capital intensity is also related to R&D activities (see Galende and 
Suárez, 1999). Hsiao and Tahmiscioglu (1997) find that capital intensive firms 
face more difficulties in financing investment projects. Consequently, capital 
intensive firms would face greater financial constrains, which may lead them to 
undertake less R&D projects, and these projects may be poorly assessed by 
capital markets because the cost of capital for capital intensive firms would be 
higher. Consequently, our last hypothesis is as follows: 
 Hypothesis 8. The impact of research and development on firm value is 
lower for capital intensive firms. 
This hypothesis can be tested by substituting the dummy variable in 
Equation (15) by another dummy variable, DCIit, which takes value 1 for firms 
whose capital intensity level is larger than the sample mean, and 0 otherwise. In 
this study, capital intensity is defined as the ratio between the replacement value 
of tangible assets and sales revenue.  
 
 




To test the hypotheses posed in the previous section we have used data from the 
eurozone countries, which have been extracted from an international database, 
Worldscope. Additionally, international data such as the growth of capital goods 
prices, the rate of interest of short term debt, and the rate of interest of long term 
debt, have been extracted from the Main Economic Indicators published by the 
Organization for Economic Cooperation and Development (OECD). 
 For each country we have constructed an unbalanced panel comprising 
companies for which information for a least six consecutive years from 1986 to 
2003 was available††. This strong requirement is a necessary condition since we 
lost one-year data in the construction of some variables (see Appendix), we lost 
another year-data because of the estimation of the model in first differences, and 
                                                 
†† Note that before this date there is no information available for research and development, 
which is the main topic of our research. 




four consecutive year information is required in order to test for second-order 
serial correlation, as Arellano and Bond (1991) point out. We need to test for 
the second-order serial correlation because our estimation method, the 
Generalized Method of Moments (GMM), is based on this assumption.  
 As occurs in La Porta et al. (2000), we had to remove Luxembourg from 
our sample, since there are just a few companies listed in Luxembourg’s stock 
exchange. We also had to remove all the countries (namely Finland and 
Portugal) for which samples with the abovementioned requirement could not be 
selected‡‡. As a result, our panel comprises Austria, Belgium, France, Germany, 
Greece, Ireland, Italy, the Netherlands and Spain. Table 1 provides the structure 
of the sample in terms of companies and number of observations per country. 
Note that the details of the data reported by the different tables of this paper are 
provided after removing the first-year data. These first-year data are only used 
to construct several variables, but not in the estimation of the models. 
Therefore, tables exclusively refer to the data used to estimate the models. Table 
2 shows the structure of the resultant unbalanced panel used in the estimation, 
according to the number of annual observations per company. To be exact, our 
unbalanced panel comprises 271 companies and 2,387 observations. Using an 
unbalanced panel for a long period (16 years) is the best way to solve the 
survival bias caused when some companies are delisted, and consequently, 
dropped from the database. Finally, Table 3 provides the allocation of all 
companies to one of nine broad economic sector groups in accordance with the 
Economic Sector Code. Note that financial services companies have been 
excluded from our study due to their own specificity. 
 Using the information of the above described database we have 
constructed all the variables in our models following the procedure detailed in 
the Appendix. Our dependent variable is a measure of firm value, and the 
explanatory variables in the basic model are residual income and research and 
development. We have also estimated an extended version of the model 
including two control variables: market share and long term debt. The summary 
statistics (mean, standard deviation, maximum and minimum) are provided by 
Table 4. To analyse how certain firm characteristics moderate the relationship 
between firm value and research and development, we have used a set of 
dummy variables constructed as explained in the Appendix§§. The number of 
zeros and ones for each dummy variable is provided in Table 5. 
 
3.2. Estimation method 
                                                 
‡‡ Note that the information on research and development usually presents a lot of missing 
values in databases. 
§§ Note that both the basic and extended versions of the model have also been estimated by 
accounting for the interactions described in Section 2. 





All the models specified in this paper have been estimated by using the panel 
data methodology. Two issues have been considered to make this choice. First, 
unlike cross-sectional analysis, panel data allow us to control for individual 
heterogeneity. This point is crucial in our study because the decision of 
undertaking R&D projects in a firm is very closely related to the firm specificity 
and, more importantly, the effect of research and development on firm value is 
strongly linked to the specificity of each firm. Therefore, to eliminate the risk of 
obtaining biased results, we have controlled for this heterogeneity by modelling 
it as an individual effect, ηi, which is then eliminated by taking first differences 















+++++ ηββ 21                                      (16) 
where the error term has several components, besides the abovementioned 
individual or firm-specific effect (ηi): dt measures the time-specific effect by the 
corresponding time dummy variables, so that we can control for the effects of 
macroeconomic variables on firm value; ci are country dummy variables 
standing for the country-specific effect, which are necessary in that our models 
are estimated using data of several countries; finally, vit is the random 
disturbance.  
 The second issue we can deal with by using the panel data methodology 
is the endogeneity problem. The endogeneity problem is likely to arise since the 
dependent variable (firm value) may also explain research and development in 
that a higher value may encourage managers to undertake new R&D projects. 
Therefore, all models have been estimated by using instruments. To be exact, 
we have used all the right-hand-side variables in the models lagged twice and 
three times as instruments. 
 Finally, we have checked for the potential misspecification of the models. 
First, we use the Hansen J statistic of over-identifying restrictions in order to 
test the absence of correlation between the instruments and the error term. 
Tables 6 to 9 show that the instruments used are valid. Second, we use the m2 
statistic, developed by Arellano and Bond (1991), in order to test for the lack of 
second-order serial correlation in the first-difference residuals. Tables 6 to 9 
show that there is not second-order serial correlation (m2) in our models. Note 
that although there is first-order serial correlation (m1), this is caused by the 
first-difference transformation of the model and, consequently, it does not 
represent a specification problem of the models. Third, our results in Tables 6 to 
9 provide good results for the following three Wald tests: z1 is a test of the joint 
significance of the reported coefficients; z2 is a test of the joint significance of 








4. Results  
 
In this section, we first summarize the main results obtained by estimating our 
basic model. Then, we comment on the findings from an extended model, which 
are totally consistent with those from the basic model. 
 
4.1. Results from the basic model 
 
Column I of Table 6 reports the results from the basic model based on the 
capital market arbitrage condition. The coefficient for the residual income 
variable is positive, as predicted by our valuation model.  In addition, the 
coefficient for the R&D variable is positive confirming the important role 
played by R&D in increasing the value of the firm. Consequently, this last result 
is in accordance with financial literature (see, for instance, Chan et al., 2001; 
Booth et al., 2006) and supports Hypothesis 1. 
 This first result is the starting point for testing other interesting 
hypotheses about how several firm characteristics moderate the positive 
relationship between firm value and R&D. Column II of Table 6 shows notable 
results on the role played by size in the abovementioned relationship. 
Specifically, we obtain that the R&D coefficient for large firms 
(β1+α1=7.3350+14.5066= 21.8416)*** is greater than the coefficient for small 
firms (β1=7.3350). This result supports Hypothesis 2 in that R&D spending has 
a greater impact on the firm value of large firms. This result is also consistent 
with the Schumpeterian hypothesis. Moreover, there are other factors that 
explain why R&D is more effective in large firms than in small ones, such as 
economies of scale, the easier access to capital market and the R&D cost 
spreading. 
 Regarding firm growth, our results provide a new view to economic 
literature. As shown in Column III of Table 6, the R&D coefficient for firms 
with a high rate of growth (β1+α1=12.1961+13.7147=25.9108, see t value for its 
statistical significance) is greater than the R&D coefficient for firms with a low 
rate of growth (β1=12.961). Our third hypothesis is totally confirmed by this 
                                                 
*** Note that the linear restriction test whose null hypothesis is H0:β1+α1=0 provides a result 
rejecting this null hypothesis, see the t value in Table 6.  




result, and we provide new evidence going further on the relation between R&D 
spending and firm growth. Specifically, we show that a firm’s growth positively 
affects the market valuation of its R&D spending. This higher valuation arises 
thanks to the greater advantage that firms with a higher rate of growth take from 
the supra-normal profits yielded by R&D projects. 
 Regarding the effect of free cash flow on the relationship between firm 
value and R&D spending, our results also provide interesting empirical 
evidence. As can be seen in column IV of Table 6, the R&D coefficient for 
HFCF firms (β1+α1=22.4653-15.8905=6.5748)††† is lower than the coefficient 
for LFCF firms (β1=22.4653). This result is consistent with our Hypothesis 4, 
and it can be interpreted as evidence supporting the free cash flow theory in that 
HFCF firms could use their free cash flow to undertake negative NPV R&D 
projects, which would be obviously rejected in the case of LFCF firms. 
 The results on how market share moderates the relationship between firm 
value and R&D spending are shown in Column I of Table 7. These results are in 
agreement with our Hypothesis 5, since they reveal that the R&D coefficient is 
higher for firms with high market share (β1+α1=12.7357+10.2647=23.0004, see 
t value for its significance), than for firms with low market share (β1=12.7357). 
Consequently, our results confirm that the higher the market share of the firm, 
the more effective the R&D spending and, therefore, the higher the market 
valuation.  Actually, there is a simple reason for this fact in that R&D spending 
yields some supra-normal profits for each euro sold; hence the overall benefits 
will be greater as the market share rises. 
 Since Rajan and Zingales (1998), the external finance dependence has 
played an important role in the recent development of economic theory.  We 
also provide interesting results on how the external finance dependence affects 
the market valuation of R&D spending.  Column II of Table 7 shows that the 
R&D coefficient is lower for firms with higher external finance dependence 
(β1+α1=22.4936–12.9414=9.5522, which is statistically significant, see t value) 
than for those with lower external finance dependence (β1=22.4936). This result 
supports our Hypothesis 6, and confirms that firms with higher dependence on 
external finance face an important handicap in order to undertake R&D projects. 
In fact, the higher information asymmetry associated with this kind of projects 
substantially increases the cost of external financing. As a result, part of the 
supra-normal profits yielded by the R&D projects are spent on paying the 
premium of external financing faced by firms highly dependent on external 
finance and, consequently, the market reaction to R&D spending is lower than 
for the remaining firms. 
                                                 
††† The t value resulting from the linear restriction test (see Table 6) tells us that this 
coefficient is significantly different from zero. 




 We now move on to the analysis of the effect of labour intensity on the 
relationship between firm value and R&D spending. As shown in Column III of 
the Table 7, the R&D coefficient is lower for labour intensive firms 
(β1+α1=19.2024–7.9051=11.2973, which is statistically significant, see t value) 
than for the remaining firms (β1=19.2024). Consequently, in agreement with 
Hypothesis 7, the market valuation of R&D spending is lower for labour 
intensive firms, since the supra-normal profits from R&D projects are diluted 
between employees. 
 Finally, we also provide results on how capital intensity affects the 
market valuation of R&D spending. Specifically, column IV of Table 7 reveals 
that the R&D coefficient is lower for capital intensive firms (β1+α1=23.2176 – 
11.4951=11.7225, statistically significant, see t value) than for the remaining 
firms (β1=23.2176). This evidence supports our last hypothesis, and shows that 
capital intensive firms face greater financial constrains and, as a result, the 
market valuation of their R&D projects is lower. 
 
4.2. Results from the extended model 
 
Green et al. (1996) derive a valuation model for R&D also based on the residual 
income. Apart from other differences in the derivation process, they include 
some control variables. Therefore, we extend on our basic model by means of 
two control variables as a robustness check for our results. Specifically, we 
enter into the model market share and long term debt as control variables‡‡‡. 



















++++ 4321 ββββ                                    (17) 
 The results for this extended model, also accounting for the interactions 
described in Section 2, are presented in Tables 8 and 9. The main characteristic 
of these results is that they are in total agreement with those for the basic model 
discussed in the previous section. specifically, the coefficients for residual 
income and R&D variables show always the expected positive sign. In addition, 
the role played by firm characteristics in moderating the relationship between 
firm value and R&D spending is exactly the same than that found in the basic 
model. Overall, this evidence provides an excellent robustness check of our 
results. 
                                                 
‡‡‡The first variable is defined as a firm’s sales over the sales of its industry, while the second 
variable is the long term debt scaled by replacement value of total assets (see Appendix for 
details).  




  Furthermore, the two control variables also throw light on the role played 
by some firm characteristics§§§. The coefficient of the long term debt variable is 
always positive revealing the benefits resulting from the fact that interest 
payments are tax deductible, while the coefficient of the market share variable 
is not significant. Consequently, this result strongly supports our approach in 
explaining the role of certain firm characteristics in that some of them (such as 
market share), despite non-significant in explaining value, play an important 





This paper focuses on how firm characteristics moderate the relationship 
between firm value and R&D spending. Taking the capital market arbitrage 
condition as our starting point, we derive a valuation model in which firm value 
depends on residual income and R&D spending. By using this model we 
interact several firm characteristics with R&D in order to investigate the role 
played by these characteristics in the market valuation of R&D spending. 
 Our results reveal a positive relationship between firm value and R&D 
spending. Furthermore, this relation is moderated by several firm 
characteristics. Particularly, size increases the market valuation of a firm’s R&D 
spending, since size provides economies of scale, easier access to capital 
markets and R&D cost spreading. Firm growth also affects positively the 
relationship between firm value and R&D spending because firms with a high 
rate of growth make the most of their supra-normal profits arising from the 
R&D projects. On the contrary, free cash flow has a negative effect on the 
abovementioned relation in that firms with high free cash flow could be tempted 
to use the free cash flow to undertake negative net present value R&D projects. 
Regarding market share, we find a positive effect on the relationship between 
firm value and R&D spending, rather than on firm value, which means that the 
supra-normal profits are highly dependent on the amount of R&D spending. The 
dependence of external finance is a handicap negatively assessed by the market 
when firms undertake R&D projects, due to the higher information asymmetry 
associated with this kind of projects. Labour intensity also has a negative effect 
on the market valuation of R&D spending, since the supra-normal profits from 
R&D projects are diluted between employees.  There is also a negative effect of 
capital intensity on the relationship between firm value and R&D spending 
because of the greater financial constrains faced by capital intensive firms.   
                                                 
§§§ The Wald test of the joint significance of the control variables provides positive results 
(see z4 in Tables 8 and 9). 




 Finally, this study provides interesting ideas in order to make decisions at 
the firm level and get a more effective R&D spending, in that the R&D intensity 
strongly depends on the characteristics of the firm. Apart from the effect of the 
financial environment, there are several firm characteristics that also moderate 
the market valuation of R&D spending. Therefore, the financial environment 
should be taken into account by the policy decision maker, whereas firm 
characteristics should be accounted for by shareholders and managers. Doing 
so, both types of decision makers would substantially increase the effectiveness 





In this Appendix we present the definition and calculation of the variables used 
in our analysis, when necessary. Except for the items we point out that come 
from the Main Economic Indicators published by the Organization for 
Economic Cooperation and Development (OECD), the remaining items used in 
the construction of the have been extracted from Worldscope. 
 
Firm value 
This variable is a derivation of our valuation model. As a result, our dependent 






where Vit  is the market value of common stock and BVit is its book value. Kit 
stands for the replacement value of total assets computed as follows: 
( itititit BFTARFK −+= )                                                                                       
where RFit is the replacement value of tangible fixed assets, TAit is the book value 
of total assets, and BFit is the book value of tangible fixed assets. The latter two 
have been obtained from the firm’s balance sheet and the first one has been 














for t>t0 and RFit0=BFit0, where t0 is the first year of the chosen period, in our case 
1986. On the other hand δit=Dit/BFit and φt=(GCGPt-GCGPt-1)/GCGPt-1, where 
GCGPt is the growth of capital goods prices extracted from the Main Economic 
Indicators. 





Residual income    
As expressed in Equation (7), this variable is defined as:    
1, −−= tiititit BVRI κπ  
where πit  stands for the net income and  Kit denotes the cost of capital. For each 
firm and time period the cost of capital has been calculated by using the Capital 
Asset Pricing Model (CAPM): 
ititititit rfrmErf βκ ))(( −+=  
where rfit  is the risk-free rate extracted from the Main Economic Indicators for 
each country and time period. The market return (rmit) was computed by using 
the market price of all the companies listed in each country regardless of whether 
or not they provide research and development information. The sample used for 
computing the market return comprises 3,147 companies and 21,072 
observations****. The company’s beta (βi) was also computed by using the market 
price and the same sample abovementioned to compute the market return item. 
 
Research and development 
This variable (RDit) was extracted from Worldscope and represents all direct and 
indirect costs related to the creation and development of new processes, 
techniques, applications and products with commercial possibilities. 
 
Market share   











                                                                                                               
where NSit denotes the net sales of firm i, and ∑ stands for the total net sales 
of its industry. To compute the net sales of the industry, we have used the 







Long term debt 
                                                 
**** The distribution of this sample across countries and industries will be provided by authors 
upon request.  
 

















where BVLTDit is the book value of the long term debt, il is the rate of interest of 
the long term debt reported in the Main Economic Indicators and lit is the average 
cost of long term debt that is defined as lit=(IPLTDit/BVLTDit), where IPLTDit is 
the interest payable on the long term debt, which has been obtained by distributing 
the interest payable between the short and long term debt depending on the 







where IPit is the interest payable, is is the rate of interest of the short term debt, 
also reported in the  Main Economic Indicators, and BVSTDit is the book value of 
the short term debt. 
 
Size dummy 
This dummy variable, DSit, is equal to 1 if the firm size is larger than the sample 
mean, and 0 otherwise.  The firm size is calculated as the natural logarithm of 
the replacement value of total assets. 
 
Growth dummy 
This dummy variable, DGRit, takes value 1 for firms whose rate of growth is 
lager than the sample mean, and 0 otherwise.  The rate of growth for each firm 










where NSit denotes the net sales. 
 
Free cash flow dummy 
This dummy variable, DFCFit takes value 1 for firms whose free cash flow level 
is higher than the sample mean, and 0 otherwise.  The free cash flow index is 










CFFCF 1    




We compute a firm’s cash flow as ititit DEPNIAPDCF −= , where NIAPDit denotes 
net income after preferred dividends, and DEPit stands for the book depreciation 
expense. 




BVSTDMVLTDPSVQ +++=     
where PSit is the value of the firm’s outstanding preferred stock. 
 
Market share dummy 
This dummy variable, DMSit, takes value 1 for firms whose market share level is 
lager than the sample mean, and 0 otherwise.   
 
External finance dependence dummy 
This dummy variable, DEFDit, takes value 1 for firms whose external finance 
dependence level is lager than the sample mean, and 0 otherwise. The external 





CFI −  
where Iit denotes investment, calculated according to the proposal by Lewellen 
and Badrinath (1997): 
Iit=NFit-NFit-1+BDit                      
where†††† NFit denotes net fixed assets and BDit is the book depreciation expense. 
 
Labour intensity dummy 
This dummy variable, DLIit, takes value 1 for firms whose labour intensity level 
is higher than the sample mean, and 0 otherwise. The labour intensity is 






where NEit  denotes the number of employees. 
 
Capital intensity dummy 
                                                 
†††† The details on the derivation process of this formula will be provided by authors upon 
request. 




This dummy variable, DCit, takes value 1 for firms whose capital intensity level 
is larger than the sample mean, and 0 otherwise. The capital intensity is 
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Structure of the samples by country 







Germany 83 30.63 722 30.25 
France 76 28.04 683 28.61 
Spain 2 0.74 17 0.71 
Netherlands 18 6.64 174 7.29 
Belgium 7 2.58 70 2.93 
Ireland 28 10.33 240 10.05 
Greece 10 3.70 78 3.27 
Austria 9 3.32 83 3.48 
Italy 38 14.02 320 13.41 
Total 271 100.00 2,387 100.00 
Data of companies for which the information is available for at least six consecutive years 
between 1986 and 2003 were extracted. After removing the first year data only used to construct 
several variables (see Appendix), the resultant samples comprise 83 companies (722 
observations) for Germany, 76 companies (683 observations) for France, 2 companies (17 
observations) for Spain, 18 companies (174 observations) for the Netherlands, 7 companies (70 
observations) for Belgium, 28 companies (240 observations) for Ireland, 10 companies (78 
observations) for Greece, 9 companies (83 observations) for Austria and 38 companies (320 
observations) for Italy.  
 
Table 2 













16 2 0.74 32 1.34 
15 5 1.84 75 3.14 
14 28 10.33 392 16.42 
13 10 3.70 130 5.45 
12 16 5.90 192 8.04 
11 17 6.27 187 7.83 
10 22 8.12 220 9.22 
9 26 9.60 234 9.80 
8 34 12.54 272 11.40 
7 27 9.96 189 7.92 
6 44 16.24 264 11.06 
5 40 14.76 200 8.38 
Total 271 100.00 2,387 100.00 
Data of companies for which the information is available for at least six consecutive years 
between 1986 and 2003 were extracted. After removing the first year data only used to construct 









Table 3  
Sample distribution by economic sector classification 









Basic Materials 43 15.88 394 16.51 
Consumer – 
Cyclical 
39 14.39 327 13.70 
Consumer – Non 
Cyclical  
48 17.71 402 16.84 
Health Care 33 12.18 330 13.82 
Energy 7 2.58 80 3.35 
Capital Goods 64 23.62 519 21.74 
Technology 25 9.22 251 10.52 
Utilities  12 4.42 84 3.52 
Total 271 100.00 2,387 100.00 
All companies in our panels have been allocated to one of nine broad economic industry groups in accordance 






Table 4  
Summary statistics 













(R&D/K)it 0.0300 0.0350 0.0000 0.4132 
MSit 0.0015 0.0036 4.21e-07 0.0416 
(LTD/K)it 0.0535 0.0449 0.0000 0.2662 
 (MV-BV)/K)it  stands for the difference between market and book value of equity, scaled by the replacement 
value of total assets, (RI/K)it is  residual income scaled by the replacement value of total assets, (R&D/K)it is 
research and development scaled by the replacement value of total assets, MSit is market share and (LTD/K)it is 
long term debt scaled by replacement value of total assets. See Appendix for details on the definitions of these 
variables. 
 





Table 5  
Dummy variables 








DSit 1,112 46.59 1,275 53.41 
DGRit 1,493 62.55 894 37.45 
DFCFitt 434 18.18 1,953 81.82 
DMSit 1,770 74.15 617 25.85 
DEFDit 1,545 64.73 842 35.27 
DLIit 1,470 61.58 917 38.42 
DCIit 1,326 55.55 1,061 44.45 
 DSit denotes a size dummy, DGRit is a growth dummy, DFCFit denotes a free cash flow dummy, DMSit is a 
market share dummy, DEFDit is an external finance dependence dummy, DLIit is a labour intensity dummy and 
DCIit is a capital intensity dummy. See Appendix for details on the definitions of these variables. 
 






Results of the basic model (I) 
























DGRit(R&D/K)it   13.7147
* 
(0.1495)  
DFCFit(R&D/K)it    
-15.8905* 
(0.8444) 
t  131.94 127.78 42.35 
z1 961.62 (2) 16800.65 (3) 10141.03 (3) 21580.58 (3) 
z2 52.16 (16) 628.79 (16) 624.99 (16) 682.60 (16) 
z3 54.11(8) 76.33 (8) 148.75 (8) 157.88 (8) 
m1 -3.22 -2.24 -3.30 -2.38 
m2 -0.87 0.58 -0.82 0.95 
Hansen 134.03 (122) 104.80 (139) 101.02 (139) 101.71 (139) 
Notes: The regressions are performed by using the panel described in Tables 1 to 3. The rest of the information 
needed to read this table is: i) Heteroskedasticity consistent asymptotic standard error in parentheses; ii) * 
indicates significance at the 1% level; iii) t  is the t-statistic for the linear restriction test under the null hypothesis 
H0:β2+α1=0; iv) z1 is a Wald test of the joint significance of the reported coefficients, asymptotically distributed as 
χ2 under the null of no relationship, degrees of freedom in parentheses; v) z2 is a Wald test of the joint significance 
of the time dummy variables, asymptotically distributed as χ2 under the null of no relationship; degrees of freedom 
in parentheses; vi) z3 is a Wald test of the joint significance of the country dummy variables, asymptotically 
distributed as χ2 under the null of no relationship; degrees of freedom in parentheses; vii) mi is a serial correlation 
test of order i using residuals in first differences, asymptotically distributed as N(0,1) under the null of no serial 
correlation; viii) Hansen is a test of the over-identifying restrictions, asymptotically distributed as χ2 under the null, 
degrees of freedom in parentheses. 





Table 7  
Results of the basic model (II) 






















   
DEFDit(R&D/K)it  -12.94138
* 
(0.3291)   




DCIit(R&D/K)it    
-7.9051*
(0.1067) 
t 40.20 27.17 58.75 77.92 
z1 1085.88 (3) 10727.40 (3) 13995.65 (3) 14246.17 (3) 
z2 130.48 (16) 492.27 (16) 193.13 (16) 474.54  (16) 
z3 306.59 (8) 125.92 (8) 50.53 (8) 105.69 (8) 
m1 -3.10 -2.55 -2.03 -2.42 
m2 -0.95 0.75 0.27 0.20 
Hansen 174.06 (139) 101.88 (139) 105.51 (139) 108.56 (139) 
Notes: The regressions are performed by using the panel described in Tables 1 to 3. The rest of the information 
needed to read this table is: i) Heteroskedasticity consistent asymptotic standard error in parentheses; ii) * 
indicates significance at the 1% level; iii) t  is the t-statistic for the linear restriction test under the null hypothesis 
H0:β2+α1=0; iv) z1 is a Wald test of the joint significance of the reported coefficients, asymptotically distributed as 
χ2 under the null of no relationship, degrees of freedom in parentheses; v) z2 is a Wald test of the joint significance 
of the time dummy variables, asymptotically distributed as χ2 under the null of no relationship; degrees of freedom 
in parentheses; vi) z3 is a Wald test of the joint significance of the country dummy variables, asymptotically 
distributed as χ2 under the null of no relationship; degrees of freedom in parentheses; vii) mi is a serial correlation 
test of order i using residuals in first differences, asymptotically distributed as N(0,1) under the null of no serial 
correlation; viii) Hansen is a test of the over-identifying restrictions, asymptotically distributed as χ2 under the null, 
degrees of freedom in parentheses. 






Results of the extended model (I) 











































DFCFit(R&D/K)it    
-16.7261* 
(0.1192) 
t  61.02 108.61 21.18 
z1 3525.52 (4) 3001.95 (5) 9091.80 (5) 9617.32 (5) 
z2 501.14 (16) 373.53 (16) 281.75 (16) 224.94 (16) 
z3 202.39 (8) 115.04 (8) 94.25 (8) 39.82 (8) 
z4 38.21 (2) 44.50 (2) 40.47 (2) 24.62 (2) 
m1 -2.99 -1.90 -3.01 -2.29 
m2 -0.90 0.61 -0.65 0.96 
Hansen 216.39 (208) 99.88 (208) 102.44 (208) 99.76 (208) 
Notes: The regressions are performed by using the panel described in Tables 1 to 3. The rest of the information 
needed to read this table is: i) Heteroskedasticity consistent asymptotic standard error in parentheses; ii) * 
indicates significance at the 1% level; iii) t  is the t-statistic for the linear restriction test under the null hypothesis 
H0:β2+α1=0; iv) z1 is a Wald test of the joint significance of the reported coefficients, asymptotically distributed as 
χ2 under the null of no relationship, degrees of freedom in parentheses; v) z2 is a Wald test of the joint significance 
of the time dummy variables, asymptotically distributed as χ2 under the null of no relationship; degrees of freedom 
in parentheses; vi) z3 is a Wald test of the joint significance of the country dummy variables, asymptotically 
distributed as χ2 under the null of no relationship; degrees of freedom in parentheses; vii) z4 is a Wald test of the 
joint significance of the control variables, asymptotically distributed as χ2 under the null of no relationship; degrees 
of freedom in parentheses; viii) mi is a serial correlation test of order i using residuals in first differences, 
asymptotically distributed as N(0,1) under the null of no serial correlation; ix) Hansen is a test of the over-
identifying restrictions, asymptotically distributed as χ2 under the null, degrees of freedom in parentheses. 






Results of the extended model (II) 
















































DCIit(R&D/K)it    
-10.1333*
(0.1826) 
t 99.05 29.76 37.10 39.71 
z1 4625.05 (5) 4214.38 (5) 7641.76 (5) 5021.96 (5) 
z2 4235.45 (16) 341.38 (16) 245.02 (16) 103.88 (16) 
z3 1884.85 (8) 82.82 (8) 121.54 (8) 84.67 (8) 
z4 243.67 (2) 41.32 (2) 81.90 (2) 24.89 (2) 
m1 -2.95 -2.27 -1.82 -2.23 
m2 -0.94 0.68 0.20 0.22 
Hansen 252.72 (208) 102.49 (208) 97.44 (208) 105.85 (208) 
Notes: The regressions are performed by using the panel described in Tables 1 to 3. The rest of the information 
needed to read this table is: i) Heteroskedasticity consistent asymptotic standard error in parentheses; ii) * 
indicates significance at the 1% level; iii) t  is the t-statistic for the linear restriction test under the null hypothesis 
H0:β2+α1=0; iv) z1 is a Wald test of the joint significance of the reported coefficients, asymptotically distributed as 
χ2 under the null of no relationship, degrees of freedom in parentheses; v) z2 is a Wald test of the joint significance 
of the time dummy variables, asymptotically distributed as χ2 under the null of no relationship; degrees of freedom 
in parentheses; vi) z3 is a Wald test of the joint significance of the country dummy variables, asymptotically 
distributed as χ2 under the null of no relationship; degrees of freedom in parentheses; vii) z4 is a Wald test of the 
joint significance of the control variables, asymptotically distributed as χ2 under the null of no relationship; degrees 
of freedom in parentheses; viii) mi is a serial correlation test of order i using residuals in first differences, 
asymptotically distributed as N(0,1) under the null of no serial correlation; ix) Hansen is a test of the over-
identifying restrictions, asymptotically distributed as χ2 under the null, degrees of freedom in parentheses. 
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